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Abstract 43 
Background: HIV-exposed uninfected (HEU) children experience increased mortality compared with 44 
their HIV-unexposed uninfected (HUU) peers.  It is unclear whether HEU children are also at increased 45 
risk for undernutrition, a modifiable risk factor for mortality. 46 
Methods: We conducted a cross-sectional, population-based survey of children under 5 years of age in 47 
five health districts in Botswana. Linear mixed-effects models were used to assess continuous outcomes 48 
while generalized estimating equations were used to estimate relative risks of stunting, wasting, and 49 
underweight between HEU (n=396) and HUU (n=1,109) children.  Secondary analyses examined 50 
potential mediation by low birthweight. 51 
Results: The association between maternal HIV-exposure and child stunting varied significantly by child 52 
age (p<0.01). HEU children <1 year and ≥2 years of age had 1.85 (95% CI: 1.03-3.31; p=0.04) and 1.41 53 
(95% CI: 1.06-1.88; p=0.02) times the risk of stunting compared with HUU children after multivariate 54 
adjustment, respectively. During the period of 1-2 years of age, when breastfeeding cessation occurred 55 
among HUU children, HUU children had increased risk of stunting compared with HEU children who 56 
were predominantly formula fed (RR: 1.56; 95% CI: 1.05-2.32; p=0.03). A mediation analysis estimated 57 
67% of the excess risk of stunting among HEU children ≥2 years was attributable to low birthweight 58 
(p=0.02). There was no difference in risk of wasting or underweight. 59 
Conclusion: HEU children are at increased risk of stunting compared with their HUU peers; however, 60 
interventions to increase birthweight may significantly ameliorate this excess risk. Interventions to 61 
support optimal growth during weaning are needed for all breastfed children. 62 
 63 
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Introduction 70 
In 2013 the World Health Organization’s guidelines for the prevention of mother-to-child HIV 71 
transmission (PMTCT) were changed to recommend all HIV-infected women initiate triple antiretrovirals 72 
in pregnancy and continue antiretrovirals for their lifetime, including throughout breastfeeding.
1
  If this 73 
plan  is implemented consistently worldwide, this public health approach holds the promise of virtually 74 
eliminating mother-to-child HIV transmission, but will also translate to over 1.5 million children being 75 
born HIV-exposed uninfected (HEU) on an annual basis.
2,3
  In resource-limited settings, HEU children 76 
experience 2- to 3-fold higher mortality compared with children born to HIV-uninfected women.
4-7
   77 
Unless the etiologies underlying this health disparity and interventions to ensure the health and survival of 78 
HEU children in resource-limited settings are identified, PMTCT successes and the expansion of 79 
antiretroviral use in pregnancy may be partially overshadowed by excess mortality among HEU children. 80 
An estimated 3.1 million children under the age of 5 years (U5) died in 2011 as a result of 81 
underlying undernutrition, or ~45% of total U5 deaths.
8
  In sub-Saharan Africa, undernutrition has been 82 
associated with one-third of all U5 deaths.
9
 In addition to the mortality consequences, restricted linear 83 
growth or stunting during early childhood has also been linked to reduced cognition, educational 84 
attainment, and lower lifetime earnings.
10,11
  There is significant overlap in sub-Saharan Africa between 85 
geographic areas where U5 undernutrition predominates and generalized HIV epidemics.  Higher 86 
mortality among HEU children in resource-limited settings like sub-Saharan Africa, where undernutrition 87 
is a leading cause of mortality, highlights the importance of understanding the association, if any, between 88 
HIV-exposure and undernutrition.    89 
In this study we utilize data from a cross-sectional population-based survey of U5 children in 90 
Botswana to examine differences in anthropometric growth, comparing HEU children with HIV-91 
unexposed uninfected (HUU) children.  We also investigate whether the strength of the associations differ 92 
by child age and explore if differences in birthweight between HEU and HUU children potentially 93 
mediates differences in postnatal growth.  94 
 95 
Methods 96 
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Study design 97 
The Determinants of Malnutrition (DoM) study was conducted between September 2013 and 98 
February 2014 within five health districts in Botswana experiencing medium to high rates of 99 
undernutrition: Francistown, Ghanzi, Kgalagadi South, Kweneng East and Selebi Phikwe.  The Republic 100 
of Botswana’s Ministry of Health collaborated with Botswana Harvard AIDS Institute Partnership to 101 
carry-out the study funded by the United States Centers for Disease Control and Prevention.  The DoM 102 
study was a cross-sectional study enrolling U5 children and their caregivers as they attended child welfare 103 
clinics (CWCs).  Parents or guardians, referred to as caregivers, provided informed written consent to 104 
participate in the study with the child or children they accompanied to CWCs. This study of HIV-105 
exposure is limited to children enrolled in the DoM study whose mothers’ HIV status during the 106 
pregnancy was known and, if the child was born to an HIV-infected mother, the child had HIV testing 107 
that was negative for HIV.  HIV-infected children and children with unknown HIV status were excluded 108 
from this analysis.  109 
Botswana has an extensive network of government run hospitals, clinics, health posts and mobile 110 
stops.  CWCs are held at almost all of these health locations and are free of charge for Botswana citizens. 111 
CWCs are structured to be attended monthly by U5 children as well-child clinics. During CWCs, a child’s 112 
weight is evaluated monthly, length/height is evaluated twice a year, and children receive scheduled 113 
immunizations. In addition, caregivers are provided with age specific nutritional supplements for 114 
children, so long as the children are between the ages of 6 months and 5 years.  As part of the national 115 
PMTCT strategy, exclusive formula feeding is promoted for all HIV-exposed infants, with provision of 116 
free infant formula throughl 12 months of age.  Formula feeding has high uptake among HIV-infected 117 
women in Botswana. 118 
 119 
Health facility and participant selection 120 
A two‐stage stratified sampling process using probability proportional to size (PPS) sampling 121 
technique was used. The sampling frame was obtained from Botswana’s Ministry of Health and it 122 
comprised all the 176 health facilities and active mobile stops that conduct CWCs in the 5 districts. In the 123 
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first stage facilities with average monthly under‐5 CWC attendance of 75 or higher were divided by 124 
district and type of the health facility (hospital, clinic, health post, and mobile stop). A total of 36 health 125 
facilities (primary sampling unit) across five districts were then selected. The number of selected primary 126 
sampling units in each district was proportional to the average monthly volume in all facilities in the 127 
district. Within each district, the number of units sampled by each type of health facility was fixed at 55 128 
children, except for the highest volume health clinic located in Mogoditshane, within the Kweneng East 129 
District Clinic, where a sample size of 110 was assigned. Facility classification as urban, peri‐urban, or 130 
rural was based upon analysis provided by Botswana’s Department of Town and Regional Planning 131 
housed within the Ministry of Local Government and Rural Development. In the second stage, caregivers 132 
attending CWCs were randomly selected each day until the target number of U5 children was reached. 133 
Children were only allowed to be sampled once during the study.  134 
 135 
Survey instrument and data collection 136 
Study activities included a questionnaire for the caregiver and chart abstraction from the child’s 137 
under‐5 health booklet to obtain birth weight, immunization records, sick visit and hospitalization data, 138 
HIV testing results of the child, if born to an HIV-infected mother, and maternal HIV status during the 139 
pregnancy.  Data collected included sex and age of the child at enrollment, birth weight, birth order of the 140 
child, feeding choice in infancy as either breast, formula feeding or a combination of breast and formula 141 
feeding, duration of infant breastfeeding, history of up to the last five episodes of diarrheal illness or 142 
respiratory infection requiring outpatient care or hospitalization of the child if applicable, location of 143 
facility, maternal marital status, primary caregiver (i.e. mother, grandmother, aunt), household income, 144 
access to tap water, flush toilet, electricity and refrigerator in the home where the child resides, and access 145 
to gas or electricity as a cooking source compared with paraffin stove or wood in the home where the 146 
child resides. Additional data included number individuals in the household where the child resides eating 147 
from the same pot (communal eating), report of food insecurity in the household where the child resides 148 
either on the day of the study visit or within the past month, and maternal age at time of the child’s birth.  149 
Food insecurity was assessed by caregiver-report of insufficient access to food either on the day of the 150 
6 
 
study visit or in the past month. These two food insecurity questions have been used in past Botswana 151 
surveys, but are not part of a validated food security instrument. 152 
Study staff trained in the acquisition of anthropometric measures used calibrated scales for weight 153 
assessment, length boards for recumbent assessment of length for children < 24 months of age, and 154 
stadiometers for height assessment of children ≥ 24 months of age.  Study procedures required assessment 155 
of the child’s weight and length/height three consecutive times at the same visit and the average of the 156 
three results was used as the final weight and length/height for the child. Length/height-for-age z score 157 
(LAZ/HAZ), weight-for-length z-score (WLZ/ WHZ), and weight-for-age z score (WAZ) were calculated 158 
using WHO child growth standards.
12
 Stunting, wasting, and underweight were defined as a LAZ/HAZ, 159 
WLZ/WHZ, and WAZ of 2 or more standard deviations below the WHO population median, respectively. 160 
 161 
Statistical methods 162 
Maternal, caregiver, and child characteristics were compared between HEU and HUU children 163 
using the Wilcoxon rank-sum test for continuous variables and the χ2 test for categorical variables. We 164 
then assessed mean differences in LAZ/HAZ, WLZ/WHZ, and WAZ for HEU versus HUU children 165 
using linear mixed effects models (PROC MIXED) to account for clustering by facility due to sampling 166 
methods.   Generalized estimating equations (GEEs) (PROC GENMOD) with log-links and exchangeable 167 
correlation matrices were used to account for clustering by facility and obtain relative risk estimates for 168 
the binomial outcomes of stunting, wasting, and underweight.
13,14
  Multivariate models were defined a 169 
priori and included covariates for maternal age (<25, 25-30, and 30+ years), maternal marital status 170 
(married, single, divorces/widowed), location of enrollment (urban, peri-urban, rural), household income 171 
<1,000 Pula per month (yes/no), electricity (yes/no), refrigerator (yes/no), tap water (yes/no), electric or 172 
gas cooking (yes/no), flush toilet (yes/no), child sex, and birth order (first born, 2-4, or 5+).  We also 173 
examined child age as an effect modifier using interaction terms in multivariate models with statistical 174 
significance of effect modification assessed using the likelihood ratio test. If statistically significant effect 175 
modification was determined, all models were presented stratified by child age.  176 
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We conducted an exploratory mediation analyses to determine the potential of low birthweight 177 
(LBW), defined as a birthweight of <2500 grams, to mediate differences in risk of child stunting between 178 
HEU and HUU children. In order to do so, we first created a multivariate base model to estimate the 179 
independent association of maternal HIV-exposure with the binary outcome of stunting. Next, we added a 180 
covariate for LBW to the base model to evaluate the potential mediating effect of LBW on the association 181 
between HEU children and stunting. We then calculated the mediation proportion and its p-value using 182 
the publicly available %Mediate macro (http://www.hsph.harvard.edu/donna-183 
spiegelman/software/mediate/).
15
 The mediation proportion is defined as the proportion of excess risk of 184 
stunting for HEU children relative to HUU children that can be attributed to elevated prevalence of low 185 
birth weight among HEU children. We also present the relationship of LBW with stunting stratified by 186 
maternal HIV status, in order to confirm the assumption of no effect modification by the mediation 187 
variable. 188 
In all analyses, missing data for covariates was retained in the analysis using the missing indicator 189 
method for variables missing greater than 1% of the observations. All p-values were 2-sided and p<0.05 190 
was considered statistically significant. Statistical analyses were performed using the SAS v 9.4 (SAS 191 
Institute Inc., Cary, NC, USA).  192 
 193 
Ethics  194 
The study was approved by the Botswana Health Research Development Committee, Center for 195 
Global Health at the Centers for Disease Control in Atlanta, USA and the Massachusetts General 196 
Hospital’s Human Subjects Committee. 197 
 198 
Results 199 
At total of 1,703 children <5 years of age were enrolled in the DoM study, of these 1,109 (65.1%) 200 
were born to HIV-uninfected mothers, 432 (25.4.8%) to HIV-infected mothers, and 162 (9.5%) to 201 
mothers with unknown HIV status in pregnancy.  Among HIV-exposed children, 396 (91.7%) were HEU, 202 
7 (1.6%) HIV-infected, and 29 (6.7%) were never tested or had an unknown HIV status at the time of the 203 
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study visit.  This study provides an evaluation of growth for the 396 HEU children and 1,109 HUU 204 
children. 205 
Table 1 presents maternal, caregiver, and child characteristics for HEU and HUU children. 206 
Mothers of HEU children tended to be older than mothers of HUU children (30.1 versus 25.9 years) and 207 
slightly more HEU children attended CWCs in urban areas (47.1% versus 42.0%). HEU children also 208 
tended to have lower socioeconomic status compared with HUU children. A significantly higher 209 
proportion of HEU children resided in households where the monthly household income was less than 210 
1000 pula per month (equivalent to ~$120 US Dollars) (37.5% versus 25.5%) and HEU households were 211 
less likely to have electricity, tap water, and refrigeration. As for child characteristics, HEU children 212 
tended to have higher birth order and were more likely to be born with low birthweight (<2500g)  213 
compared with HUU children (18.3% versus 10.8%). In addition, 94.7% of HEU children were 214 
exclusively formula fed from birth due to the national PMTCT strategy, while only 21.7% of HUU 215 
children received infant formula. 216 
We examined the association of HIV-exposure with linear growth (LAZ/HAZ) and determined 217 
the strength of association significantly varied by child age (p-value for effect modification: <0.01). As 218 
shown in Figure 1, the prevalence of stunting was greater for HEU children compared with HUU children 219 
during the first year of life and from 2-5 years of age.  During the period of 1-2 years of age, HUU 220 
children had increased prevalence of stunting. Table 2 presents univariate and multivariate mean 221 
differences in LAZ/HAZ and relative risk of stunting for HEU versus HUU children stratified by child 222 
age. Among children <1 year of age, HEU children had significantly increased risk of stunting compared 223 
with HUU children after multivariate adjustment (RR: 1.91; 95% CI: 1.17-3.09; p=0.01). For children 1-2 224 
years of age, HEU children had reduced risk of stunting (RR: 0.64; 95% CI: 0.43-0.95; p=0.03) compared 225 
with HUU children in multivariate models. Among children 2-5 years of age, multivariate models 226 
indicated HEU children had significantly increased risk of stunting (RR: 1.42; 95% CI: 1.07-1.87; 227 
p=0.01) compared with HUU children.  228 
In order to explore potential mechanisms leading to this qualitative change in the direction of the 229 
association by child age, we examined the relationship of time since breastfeeding cessation with stunting 230 
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among HUU children. Among HUU children aged 1-3 years, those who were currently breastfed had a 231 
prevalence of stunting of 18.9%, while among similarly aged children who had stopped breastfeeding for 232 
<3 months the prevalence of stunting sharply increased to 36.0% (see Supplemental Table 1, which shows 233 
stunting prevalence by time since breastfeeding cessation). The prevalence of stunting gradually 234 
decreased with increased time since breastfeeding cessation to 22.5% for HUU children who had not 235 
breastfed for >12 months.  In multivariate analyses, HUU children who had stopped breastfeeding within 236 
the last 3 months had 1.76 times the risk of being stunted at the time of the study visit (95% CI: 0.96-237 
3.22; p=0.07) compared with similarly aged breastfed HUU children (see Supplemental Table 2, which 238 
shows the association of time since breastfeeding cessation with stunting). 239 
We also conducted exploratory analyses to determine the potential for low birthweight to mediate 240 
the observed increased risk of child stunting among HEU children <1 years and ≥ 2 years.  Table 3 241 
presents mediation analysis results. HEU children <1 year and ≥ 2 years had roughly twice the prevalence 242 
of LBW (<2500g) compared with similarly aged HUU children, and within both age strata, LBW was 243 
strongly associated with increased risk of stunting. Among children <1 years, LBW was found to be a 244 
significant mediator of the relationship of HIV-exposure with stunting and the estimated mediation 245 
proportion was 35% (p=0.04). For children ≥ 2 years, 67% of the excess risk of stunting for HEU children 246 
relative to HUU children could be attributed to LBW (p=0.02). We found no significant difference in the 247 
association of LBW with stunting among HEU children 2-5 years (RR: 1.77; 95% CI: 0.57-5.53) versus 248 
HUU children 2-5 years (RR: 2.33; 95% CI: 1.33-4.14) (p-value for interaction: 0.22), which confirms the 249 
assumption of no effect modification by the mediation variable. 250 
In Table 4 we present mean differences in WLZ/WHZ and WAZ, along with relative risk of 251 
wasting and underweight for HEU versus HUU children.  We found no significant evidence of effect 252 
modification by child age for all analyses (all p-values for interaction > 0.05) and therefore results are 253 
presented without age stratification.  There was no significant difference in risk of wasting or underweight 254 
or difference in WLZ/WHZ for HEU versus HUU children in multivariate models (all p-values >0.05). In 255 
univariate analyses HEU children had significantly decreased mean WAZ (-0.15; 95% CI:-0.29 - -0.01; 256 
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p=0.03), and a similar magnitude of the association was found in multivariate models but the results did 257 
not reach statistical significance (-0.13; 95% CI: -0.27-0.02; p=0.09).  258 
 259 
Discussion 260 
In this study we found maternal HIV-exposure increased the risk of stunting for Botswana 261 
children who were under 1 year or greater than 2 years of age. In secondary mediation analyses, increased 262 
prevalence of LBW among HEU children was found to be a significant mediator of the stunting 263 
association.  During the period of 1-2 years of age, when weaning typically occurs in Botswana among 264 
children born to HIV-uninfected mothers, HUU children had an increased prevalence of stunting 265 
compared with HEU children.  We did not find significant differences in risk of wasting and underweight 266 
between HEU and HUU children in multivariate analyses. 267 
In this study we determined maternal HIV-exposure was associated with increased risk of 268 
stunting, but the strength of the relationship was dependent on child age. Previous studies comparing 269 
linear growth of HEU and HUU children have reported mixed results, but the majority of studies have 270 
found no association.
16-23
 Nevertheless, there are a few studies which have noted growth deficits in HEU 271 
children, including a recent cross-sectional survey of HEU Ugandan infants (mean age 5 months) which 272 
found significantly increased risk of both stunting and wasting.
18
  A Kenyan study also found 273 
significantly lower HAZ for HEU infants as compared to HUU infants at 1.5 months after birth.
19
 A few 274 
potential mechanisms, independent of maternal sociodemographic differences, which may have led to 275 
increased risk of linear growth faltering among HEU children compared with HUU children include: 276 
exposure to antiretroviral drugs, deficits in immune responses to vaccination as well as pathogens, and 277 
increased exposure to other infections.
24-29
  278 
To our knowledge we are the first study to utilize mediation analyses to estimate the proportion of 279 
stunting attributable to low birthweight, a potentially modifiable risk factor.   In our cohort, we estimated 280 
67% of the excess risk of stunting for HEU children over 2-5 years of age could be attributed to increased 281 
prevalence of LBW compared with HUU children. We have previously found that HEU children in 282 
Botswana exposed to combined antiretroviral treatment (cART) in utero had lower length at birth, 6 and 283 
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24 months of age compared with zidovudine monotherapy-exposed HEU infants.
29,30
 Accordingly, there 284 
may be a greater impact on linear growth when triple antiretrovirals are provided to HIV-infected mothers 285 
in pregnancy compared with monotherapy. The majority of previous HEU child growth studies were 286 
conducted before the availability of cART in resource-limited settings, which may partially explain their 287 
null associations.
16,20-23
 Nevertheless, a few of these studies noted lower birthweights among HEU 288 
children compared with HUU children
20,21
.  Research is urgently needed to identify mechanisms by which 289 
cART during pregnancy influences birth weight and impairs postnatal linear growth, so that the safest 290 
combination of triple antiretrovirals for HIV-infected pregnant women and their children can be 291 
identified.  292 
In this study, we noted a sharp increase in the prevalence of stunting among HUU children 1-2 293 
years of age, particularly during the initial months after cessation of breastfeeding. There is a large body 294 
of literature indicating the importance of continuing breastfeeding and providing nutritious 295 
complementary foods during the first 2 years of life for child survival and growth.
32-36
 A prospective 296 
cohort study of Kenyan children (mean age of 14 months at cohort entry) found children who continued 297 
breastfeeding throughout a 6 month follow-up  period had significantly better length and weight outcomes 298 
compared with children who breastfed for <3 months of the follow-up period.
35
  As almost all HEU 299 
children were formula fed in our study population, we were not able to examine breastfeeding cessation 300 
as a  risk factor for stunting among HEUs; however, there is evidence that continued breastfeeding during 301 
the first two years of life also improves growth among HEU breastfed populations.
36
  Overall, there is a 302 
strong programmatic need for monitoring growth and providing support during the period of 303 
complementary feeding introduction and breastfeeding cessation regardless of the HIV-exposure status of 304 
the child. 305 
There are a few limitations to this study. First, due to the HIV-testing algorithm there may be a 306 
small amount of misclassification of child HIV status. The HIV testing algorithm in this population is a 307 
DNA PCR at 6 weeks with a follow-up ELISA at 18 months for non-breastfed HEU infants. As a result, 308 
there is a possibility that a very small number of children became HIV-infected after a 6 week negative 309 
HIV test but were not yet retested at 18 months; however in this population of almost all formula fed 310 
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HEU infants, the number of children who seroconverted after 6 weeks is likely very small. In addition, 311 
due to the cross-sectional nature of the study, we did not have information on the duration and type of 312 
antiretrovirals received by HIV-infected mothers during pregnancy. Further, we also did not have access 313 
to other maternal health indicators including height, body mass index, and anemia. As a result, poorer 314 
maternal health in pregnancy for HEU children may partially explain our observed differences in linear 315 
growth. Given the fact that an individual’s overall growth and health is strongly influenced by the first 316 
1,000 days of life, from conception to their second birthday, it is imperative to optimize maternal health, 317 
if we want optimize the growth of children.  We also did not have data on the birth length of the child, 318 
which may be a significant mediator of postnatal growth, independent of LBW.  In a previous study we 319 
found HEU children exposed to cART in utero had lower length at birth compared with zidovudine 320 
monotherapy-exposed children.
30,31
 The cross-sectional nature of the study has some limitations but we 321 
also note that the children sampled in this survey are likely more representative of the general HEU child 322 
population than other studies using secondary analyses of clinical trials and follow-up studies which often 323 
provide improved medical care and growth monitoring.  324 
Overall, we found HEU Botswana children under 1 year and 2-5 years of age had increased risk 325 
of stunting compared with their HUU peers. A mediation analysis indicated that a significant proportion 326 
of this excess risk appears to be linked to increased prevalence of low birthweight among HEU children. 327 
As a result, future research needs to determine the underlying mechanisms leading to low birthweight 328 
among children of HIV-infected mothers, which includes determining optimal cART regimens for the 329 
health of pregnant women as well as growth of their HEU children.  This research is urgently needed as 330 
the number of HEU children is rapidly expanding due to continued success of PMTCT programs and the 331 
increasing number of countries transitioning to Option B+ in their national PMTCT guidelines.  332 
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Figure Titles and Captions 
 
Figure 1 Title.  Prevalence of stunting (HAZ < -2) for HEU vs HUU children by child age 
Figure 1 Caption.   
Abbreviations: HAZ: height-for-age z-score; HEU: HIV-exposed uninfected; HUU: HIV-unexposed 
uninfected  
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Table 1. Maternal, caregiver, and child characteristics for HEU (n=396) and HUU (n=1,109) children <5 
years of age. 
 HEU children 
(n=396) 
Mean ± SD or 
Frequency (%) 
HUU children 
(n=1,109) 
Mean ± SD or 
Frequency (%) p-value 
Maternal and household characteristics    
Maternal age in years 30.1 ± 5.7 25.9 ± 6.0 <0.01 
Marital status    
     Single 331 (85.5) 932 (84.0) 0.18 
     Married 52 (13.5) 174 (15.7)  
     Divorced or widowed 4 (1.0) 4 (0.3)  
Primary caregiver is parent or grandparent 336 (86.7) 975 (87.9) 0.53 
Location of enrollment health facility    
     Urban 182 (47.1) 466 (42.0) 0.04 
     Peri-urban 138 (35.5) 384 (34.6)  
     Rural 67 (17.4) 259 (23.4)  
Household income <1,000 Pula per month 145 (37.5) 282 (25.5) <0.01 
No electricity in the home 165 (42.7) 383 (34.5) <0.01 
No refrigerator in the home 197 (51.0) 484 (43.6) 0.01 
No electric or gas cooking source 131 (33.8) 326 (29.4) 0.11 
No tap water in the home 258 (66.5) 677 (61.0) 0.05 
No flush toilet 242 (62.5) 642 (57.8) 0.10 
Report of food insecurity in past month 112 (29.0) 251 (22.8) 0.01 
    
Child characteristics    
Male  213 (55.1) 509 (45.9) <0.01 
Child age in years 2.1 ± 1.3 2.1 ± 1.4 0.37 
Birth order    
     Firstborn 78 (20.3) 496 (44.7) <0.01 
     2-4
th
 child 268 (67.7) 552 (49.8)  
     5+ child 41 (10.5) 62 (5.6)  
Low birthweight <2500grams 71 (18.3) 120 (10.8) <0.01 
Exclusively formula fed  375 (94.7) 241 (21.7) <0.01 
  
Table 1 Caption 
Abbreviations: HEU: HIV-exposed uninfected; HUU: HIV-unexposed uninfected; SD: standard deviation 
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Table 2. Mean difference in LAZ/HAZ and relative risk of stunting for HEU children (n=396) as 
compared to HUU children (n=1,109) stratified by child age (p-value for effect modification by age 
<0.01). 
 
 Mean              
LAZ/HAZ ± SD       
or % stunting 
Univariate
1
 mean 
difference or relative 
risk (95% CI) p-value 
Multivariate
1,2
 mean 
difference or relative 
risk (95% CI) p-value 
Mean difference LAZ/HAZ      
Under 1 year of age      
     HEU children (n=100) -0.54 ± 1.8 -0.20 (-0.58-0.18) 0.30 -0.22 (-0.64-0.19) 0.30 
     HUU children (n=283) -0.25 ± 1.6 Ref.   Ref.   
1-2 years of age      
     HEU children (n=109) -1.13 ± 1.3 +0.03 (-0.29 – 0.35) 0.86 +0.07 (-0.28-0.41) 0.71 
     HUU children (n=282) -1.18 ± 1.6 Ref.   Ref.   
2-5 years of age      
     HEU children (n=187) -1.44 ± 1.3 -0.25 (-0.45- -0.06) 0.01 -0.20 (-0.41- 0.01) 0.06 
     HUU children (n=544) -1.19 ± 1.2 Ref.  Ref.   
Relative risk of stunting      
Under 1 year of age      
     HEU children (n=100) 20.0%  1.76 (1.12-2.76) 0.01 1.91 (1.17-3.09) 0.01 
     HUU children (n=283) 11.0%  Ref.  Ref.   
1-2 years of age      
     HEU children (n=109) 22.9% 0.76 (0.53-1.08) 0.13 0.64 (0.43-0.95) 0.03 
     HUU children (n=282) 29.8% Ref.  Ref.   
2-5 years of age      
     HEU children (n=187) 31.0% 1.47 (1.18-1.83) <0.01 1.42 (1.07-1.87) 0.01 
     HUU children (n=544) 20.8% Ref.   Ref.  
 
Table 2 Captions 
1
Univariate and multivariate models accounted for clustering by facility. 
2
Multivariate models accounted for clustering by facility and adjusted for maternal age (<25, 25-30, and 
30+ years), maternal marital status (married, single, divorces/widowed), location of enrollment (urban, 
peri-urban, rural), household income <1,000 Pula per month (yes/no), electricity (yes/no), refrigerator 
(yes/no), tap water (yes/no), electric or gas cooking (yes/no), flush toilet (yes/no), child sex, and birth 
order (first born, 2-4, or 5+)  
Abbreviations: CI: confidence interval; HAZ: height-for-age z-score; HEU: HIV-exposed uninfected; 
HUU: HIV-unexposed uninfected; LAZ: length-for-age z-score; SD: standard deviation 
20 
 
Table 3. Mediation analysis of the association of child HIV-exposure with stunting by low birth weight stratified by child age 
Child age % Stunted 
% LBW 
<2500g 
Multivariate
1,2 
adjusted relative risk 
(95% CI) of stunting 
for LBW of <2500g 
versus  birth weight 
≥2500g 
Multivariate
1
 
adjusted relative 
risk (95% CI) of  
stunting for HEU 
vs. HUU                           
(not adjusted for 
LBW) 
Multivariate
2,3 
adjusted 
relative risk  of stunting 
for HEU vs. HUU                                                      
(adjusted for LBW) 
Estimated mediation 
proportion for LBW
(p-value) 
<1 year            
(HEU n=100) 
(HEU n=283) 
 HEU: 20.0% 
HUU: 11.0% 
 HEU: 15.0% 
HUU: 8.1% 
2.81 (1.45-5.34) 1.63 (1.07-2.47) 1.49 (0.88-2.52) 35% (p=0.04) 
2-5 years 
(HEU n=187) 
(HEU n=544) 
 HEU: 31.0% 
HUU: 20.8% 
 HEU: 21.1% 
HUU: 11.6% 
2.02 (1.41-2.88) 1.43 (1.08-1.90) 1.12 (0.85-1.49) 67% (p=0.02) 
 
Table 3 Captions 
1 Models restricted to children with a non-missing birth weights. Multivariate models were adjusted for maternal age (<25, 25-30, and 30+ years), 
maternal marital status (married, single, divorces/widowed), location of enrollment (urban, peri-urban, rural), household income <1,000 Pula per 
month (yes/no), electricity (yes/no), refrigerator (yes/no), tap water (yes/no), electric or gas cooking (yes/no), flush toilet (yes/no), child sex, birth 
order (first born, 2-4, or 5+). 
2
Includes adjustment for maternal HIV status 
3
Includes low birth weight (<2500g) 
Abbreviations: CI: confidence interval; HEU: HIV-exposed uninfected; HUU: HIV-unexposed uninfected; LBW: low birth weight 
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Table 4. Mean difference in WHZ and WAZ and relative risk of wasting and underweight for HEU 
children (n=396) as compared to HUU children (n=1,109) 
 
 
 
Mean                     
z-score ± SD or %  
Univariate
1 
mean 
difference or relative 
risk (95% CI) p-value 
Multivariate
1,2
 mean 
difference or relative 
risk (95% CI) p-value 
Mean difference WLZ/WHZ      
     HEU children (n=396) -0.20 ± 1.5 -0.06 (-0.22-0.10) 0.44 -0.03 (-0.21- 0.14) 0.69 
     HUU children (n=1,109) -0.15 ± 1.4 Ref.   Ref.  
Relative risk of wasting
3
      
     HEU children (n=396) 9.6% 1.29 (0.96-1.72) 0.09 1.15 (0.95-1.38) 0.15 
     HUU children (n=1,109) 7.5% Ref.   Ref.   
Mean difference WAZ      
     HEU children (n=396) -0.79 ± 1.2 -0.15 (-0.29- -0.01) 0.03 -0.13 (-0.27-0.02) 0.09 
     HUU children (n=1,109) -0.63 ± 1.3 Ref.  Ref.  
Relative risk of underweight
2
      
     HEU children (n=396) 15.9% 1.26 (1.00-1.58) 0.05 1.02 (0.80-1.29) 0.87 
     HUU children (n=1,109) 12.5% Ref.   Ref.  
 
 
Table 4 Captions 
1
Univariate and multivariate models accounted for clustering by facility. 
2
Multivariate models adjusted for maternal age (<25, 25-30, and 30+ years), maternal marital status 
(married, single, divorces/widowed), location of enrollment (urban, peri-urban, rural), household income 
<1,000 Pula per month (yes/no), electricity (yes/no), refrigerator (yes/no), tap water (yes/no), electric or F 
3
Wasting defined as WHZ < -2 and underweight defined as WAZ < -2. 
Abbreviations: CI: confidence interval; HEU: HIV-exposed uninfected; HUU: HIV-unexposed 
uninfected; SD: standard deviation; WAZ: weight-for-age z-score; WHZ: weight-for-height z-score; 
WLZ: weight-for-length z-score 
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Figure 1 Title.  Prevalence of stunting (HAZ < -2) for HEU vs HUU children by child age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: HAZ: height-for-age z-score; HEU: HIV-exposed uninfected; HUU: HIV-unexposed 
uninfected  
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Online Supporting Material 
 
SUPPLEMENTAL TABLE 1. Prevalence of stunting by time since cessation of breastfeeding for HIV-
unexposed uninfected children 1-3 years of age (n=376) 
 
Time since cessation of 
breastfeeding 
% Stunted                                   
(Number stunted/total) 
Current breastfeeding 18.9% (11/58) 
No breastmilk <3 months 36.0% (18/50) 
No breastmilk 3-6 months 26.5% (9/34) 
No breastmilk 6-12 months 34.4% (33/96) 
No breastmilk 12 months + 22.5% (31/138) 
 
 
 
 
